CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
68.94
-1.05 (-1.50%)
Aug 28, 2025, 3:45 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $67.21 billion as of August 28, 2025. Its market cap has decreased by -31.38% in one year.
Market Cap
67.21B
Enterprise Value
78.56B
Revenue
15.56B
Ranking
n/a
PE Ratio
22.39
Stock Price
$68.94
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 67.21B, an increase of 29,099.31%. That is a compound annual growth rate of 19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 66.86B | -20.75% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 396.18M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 359.30M |